{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-21-000020","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2021-08-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.732359+00:00","generated_at":"2026-06-29T10:16:58.248583+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Clover Health CFO Joseph Wagner departs; Mark Herbers named interim CFO","bullets":["Joseph Wagner stepped down as CFO on August 13, 2021; will provide consulting services for 12 months at $10,000 per month.","Mark Herbers (Director at AlixPartners) appointed interim CFO; company pays $175,000 per month to APS for his services.","Herbers will serve as principal financial and accounting officer while permanent CFO search is conducted.","Separation agreement extends post-termination exercise period of Wagner's vested stock options by one year.","If consulting period is terminated early, company pays Wagner a lump sum equal to remaining monthly fees."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-21-000020","json":"https://secwatch.observer/filing/0001801170-21-000020.json","markdown":"https://secwatch.observer/filing/0001801170-21-000020.md","text":"https://secwatch.observer/filing/0001801170-21-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117021000020/0001801170-21-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117021000020/clov-20210813.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T10:16:58.248583+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"349a7825e7","claim":"Joseph Wagner departed as Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.","evidence_excerpt":"On July 15, 2021, Clover Health Investments, Corp. (the “Company”) announced that Joseph Wagner, the Company’s Chief Financial Officer, would be stepping down as an officer of the company on August 13, 2021 (the “Departure Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117021000020/0001801170-21-000020-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"e4dc6e4826","claim":"Mark Herbers was appointed as interim Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.","evidence_excerpt":"On August 13, 2021, the Company’s Board of Directors appointed Mr. Herbers as interim Chief Financial Officer of the Company, to serve as the Company’s principal financial officer and principal accounting officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117021000020/0001801170-21-000020-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}